Strategic reorganisation - impact on antenatal screening service for first trimester combined test in down's syndrome

2011 ◽  
Vol 96 (Supplement 1) ◽  
pp. Fa62-Fa63
Author(s):  
M. Ghosh ◽  
J. Baker ◽  
J. Finn ◽  
A. Phillips ◽  
D. Churchill
Author(s):  
Gillian M. Tringham ◽  
Tariq S. Nawaz ◽  
Stephen Holding ◽  
Jane Mcfarlane ◽  
Stephen W. Lindow

2018 ◽  
Vol 25 (3) ◽  
pp. 114-118
Author(s):  
Drahomira Springer ◽  
Jaroslav Loucky ◽  
Pavel Tesner ◽  
David Cutka ◽  
David Stejskal ◽  
...  

Objective In the Czech Republic, over 97% of all pregnant women undergo some type of antenatal screening for Down’s syndrome. In about 95% of cases with a confirmed fetal chromosomal abnormality, the pregnancy is terminated. The most commonly used test is the first trimester combined test. We investigated the impact of implementing an integrated sequential test to improve the detection of Down’s syndrome pregnancies. Methods Data on the incidence of congenital defects, number of births, and affected pregnancies terminated are recorded in the National Registry of Congenital Anomalies. Anonymous data on cases of Down’s syndrome diagnosed antenatally or postnatally between 2010 and 2015 in one of the large antenatal care centers were analyzed. Results There were 600 diagnoses of Down’s syndrome (5.7 per 1000 births), 90% of which were made antenatally. Of antenatally detected cases, 80% were indicated for diagnostic procedure by multimarker screening results. In the multimarker screen positive group, 75% cases were first trimester positive and 25% second trimester positive (most of these had positive integrated test results). Among Down’s syndrome cases indicated for antenatal diagnosis by multimarker screening results 6.25% (n = 26) were first trimester negative, and became positive after integration with the second trimester screening results. Conclusions Results from five major Czech antenatal centers confirm that an integrated sequential test would detect 80–85% of Down’s syndrome fetuses in the first trimester and at least an extra 5–10% of Down’s syndrome pregnancies in the second trimester of pregnancy. These are important data that should be considered in implementing the national antenatal screening program.


Ultrasound ◽  
2005 ◽  
Vol 13 (4) ◽  
pp. 226-230 ◽  
Author(s):  
B. Stenberg ◽  
R. Lee ◽  
A. M. Dixon

This review is based on a third-year undergraduate project undertaken by Ben Stenberg and submitted as part of a BSc (Honours) Radiography award at the University of Teesside. The project and this report reviews the concept of antenatal screening for Down's syndrome, it explores the role of ultrasound and other available tests, and considers sensitivities and potential for errors in a first trimester screening service. The review employs library based literature review methodology and its limitations reflect the size and scope of projects performed within undergraduate research regulations.


Author(s):  
Angela Ballantyne ◽  
Lorna Rashid ◽  
Rebecca Pattenden

Background Maternal serum free beta human chorionic gonadotrophin (free β-hCG) is used as a biomarker in first trimester screening for fetal Down’s syndrome. Production of free β-hCG can occur in vitro in a time- and temperature-dependent manner; thus, the current Scottish screening protocol states samples must be received by the laboratory within 72 h. To assess the validity of the protocol, an audit was conducted to determine the impact of transit time on maternal serum free β-hCG multiple of median (MoM) values in the Scottish screened population. Methods Corrected MoM values from antenatal screening carried out over one year (April 2017 to March 2018) were stratified according to sample transit time and compared. To investigate possible environmental temperature effects, the data were split according to season and maternal serum free β-hCG concentrations from summer and winter compared. Results Of the 28,368 samples included in the study, 24,368 were received on the day of phlebotomy or after one day in transit. Only 1.5% of samples were received after 3 days in transit. The difference in maternal serum free β-hCG MoM values due to transit time was not significant. No statistical difference was found between maternal serum free β-hCG concentrations from samples collected in summer and winter months. Conclusion The current sample receipt protocol in use by the Scottish Down’s syndrome screening programme is fit for purpose.


2012 ◽  
Vol 19 (2) ◽  
pp. 68-71 ◽  
Author(s):  
Zheng-You Miao ◽  
Xia Liu ◽  
Tong-Kun Shi ◽  
Ying Xu ◽  
Qin-Hao Song ◽  
...  

2019 ◽  
Vol 70 (1) ◽  
pp. 12-17
Author(s):  
Seshandri Suresh ◽  
Howard S. Cuckle ◽  
Sujatha Jagadeesh ◽  
Kushagradhi Ghosh ◽  
Gayathri Vemavarapu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document